AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2024
Feb 16, 2024
32559_dirs_2024-02-15_bdeae868-60c5-4c5e-b151-39117dedac84.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2024-02-07
Reporting Person: Burroughs Amy L. (N/A)